Broadfin Capital, LLC - DERMA SCIENCES INC ownership

DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 52 filers reported holding DERMA SCIENCES INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Broadfin Capital, LLC ownership history of DERMA SCIENCES INC
ValueSharesWeighting
Q4 2016$13,323,000
+11.3%
2,562,1040.0%1.48%
+38.0%
Q3 2016$11,965,000
+18.5%
2,562,1040.0%1.07%
+9.3%
Q2 2016$10,095,000
+27.1%
2,562,1040.0%0.98%
+27.9%
Q1 2016$7,943,000
-32.2%
2,562,1040.0%0.77%
+6.5%
Q4 2015$11,709,000
+5.2%
2,562,104
+8.5%
0.72%
+16.3%
Q3 2015$11,126,000
-32.9%
2,362,104
+1.9%
0.62%
-30.6%
Q2 2015$16,593,000
-8.0%
2,317,489
+8.8%
0.89%
-36.6%
Q1 2015$18,045,000
-47.8%
2,130,477
-42.6%
1.41%
-6.5%
Q4 2014$34,576,000
+127.5%
3,713,754
+103.6%
1.50%
-5.6%
Q3 2014$15,197,000
-64.0%
1,824,377
-50.0%
1.59%
-23.3%
Q2 2014$42,180,000
+99.2%
3,648,754
+118.5%
2.08%
+1.2%
Q1 2014$21,173,000
+124.5%
1,669,777
+91.6%
2.05%
+64.9%
Q4 2013$9,431,000
-1.3%
871,598
+13.0%
1.24%
-26.7%
Q3 2013$9,552,000
-7.7%
771,598
-0.4%
1.70%
-16.2%
Q2 2013$10,346,000775,0002.02%
Other shareholders
DERMA SCIENCES INC shareholders Q4 2016
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,148,292$13,275,0005.90%
DAFNA Capital Management LLC 384,794$4,448,0004.22%
Consonance Capital Management LP 1,451,692$16,782,0002.50%
Broadfin Capital, LLC 3,648,754$42,180,0002.08%
Redmile Group, LLC 600,677$6,944,0000.84%
ORACLE INVESTMENT MANAGEMENT INC 492,796$5,696,722,0000.69%
Senvest Management, LLC 593,665$6,863,0000.60%
HealthCor Management, L.P. 920,000$10,635,0000.53%
Baker Brothers Advisors 3,537,137$40,889,0000.50%
ROANOKE ASSET MANAGEMENT CORP/ NY 112,117$1,296,0000.50%
View complete list of DERMA SCIENCES INC shareholders